These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15469994)

  • 1. Design of fully active FGF-1 variants with increased stability.
    Zakrzewska M; Krowarsch D; Wiedlocha A; Otlewski J
    Protein Eng Des Sel; 2004 Aug; 17(8):603-11. PubMed ID: 15469994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action.
    Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J
    J Mol Biol; 2005 Sep; 352(4):860-75. PubMed ID: 16126225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of a highly stable mutant of human fibroblast growth factor 1.
    Szlachcic A; Zakrzewska M; Krowarsch D; Os V; Helland R; Smalås AO; Otlewski J
    Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):67-73. PubMed ID: 19153468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements of FGF-1 for receptor binding and translocation into cells.
    Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J
    Biochemistry; 2006 Dec; 45(51):15338-48. PubMed ID: 17176056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two nuclear localization signals required for transport from the cytosol to the nucleus of externally added FGF-1 translocated into cells.
    Wesche J; Małecki J; Wiedłocha A; Ehsani M; Marcinkowska E; Nilsen T; Olsnes S
    Biochemistry; 2005 Apr; 44(16):6071-80. PubMed ID: 15835896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function studies of FGF-1: dissociation and partial reconstitution of certain of its biological activities.
    Burgess WH; Friesel R; Winkles JA
    Mol Reprod Dev; 1994 Sep; 39(1):56-60; discussion 60-1. PubMed ID: 7528028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size limitation in translocation of fibroblast growth factor 1 fusion proteins across the endosomal membrane.
    Zakrzewska M; Zhen Y; Wiedlocha A; Olsnes S; Wesche J
    Biochemistry; 2009 Aug; 48(30):7209-18. PubMed ID: 19558187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of type I 4:6 to 3:5 beta-turn types in human acidic fibroblast growth factor: effects upon structure, stability, folding, and mitogenic function.
    Lee J; Dubey VK; Somasundaram T; Blaber M
    Proteins; 2006 Mar; 62(3):686-97. PubMed ID: 16355415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.
    Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S
    J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetric primary and tertiary structure mutations within a symmetric superfold: a solution, not a constraint, to achieve a foldable polypeptide.
    Brych SR; Dubey VK; Bienkiewicz E; Lee J; Logan TM; Blaber M
    J Mol Biol; 2004 Nov; 344(3):769-80. PubMed ID: 15533444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spackling the crack: stabilizing human fibroblast growth factor-1 by targeting the N and C terminus beta-strand interactions.
    Dubey VK; Lee J; Somasundaram T; Blaber S; Blaber M
    J Mol Biol; 2007 Aug; 371(1):256-68. PubMed ID: 17570396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of the fibroblast growth factor-2 gene led to a marked enhancement in secretion and stability of the recombinant fibroblast growth factor-2 protein.
    Chen ST; Gysin R; Kapur S; Baylink DJ; Lau KH
    J Cell Biochem; 2007 Apr; 100(6):1493-508. PubMed ID: 17243099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different roles of N- and C- termini in the functional activity of FGF21.
    Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
    J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of AKT/PKB signaling in fibroblast growth factor-1 (FGF-1)-induced angiogenesis in the chicken chorioallantoic membrane (CAM).
    Forough R; Weylie B; Patel C; Ambrus S; Singh US; Zhu J
    J Cell Biochem; 2005 Jan; 94(1):109-16. PubMed ID: 15517595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.
    Dubey VK; Lee J; Blaber M
    Protein Sci; 2005 Sep; 14(9):2315-23. PubMed ID: 16081654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.